Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Novel oral anticoagulants and reversal agents: Considerations for clinical development.

Novel oral anticoagulants and reversal agents: Considerations for clinical development. Am Heart J. 2015 Jun; 169(6):751-7.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.